The VP of Clinical Operations is accountable for the integrated strategy, leadership, and delivery of operational aspects of early‑stage clinical development for the company’s pipeline of therapies targeting immune‑mediated diseases.
This executive will be responsible for planning and executing global IND/CTA/FDA/China-enabling development first‑in‑human (FIH), Phase 1, Phase 1b proof‑of‑mechanism (PoM), and Phase 2a proof‑of‑concept (PoC) studies, with the scope to continue into later-stage clinical development as programs mature. The role requires deep expertise in early clinical development, strong scientific and operational judgment, and the ability to drive high‑quality execution in fast‑moving, innovative environments.
This leader will shape the operational strategy for early programs, build a world‑class clinical operations function, and ensure seamless global execution across multiple geographies and regulatory landscapes.
Working through a cross-functional Clinical Operations Team, the VP of Clinical Operations will provide unified operational leadership, integrating scientific, clinical, regulatory, CMC, safety, translational, and commercial considerations into a coherent operational execution strategy and plan.
This plan will reflect the program vision, Target Product Profile, and value proposition; define clear operational objectives and decision criteria; identify and manage critical risks; and enable timely, evidence-based decisions at key investment and governance milestones.
The VP of Clinical Operations will lead by influence across functions and geographies. They will create a high-performing Clinical Operations team with clear accountabilities, transparent decision-making, and strong execution discipline.
The of Clinical Operations will work closely with Research, Pre-clinical Development, Clinical Development, Translational Science, Biomarkers, Clinical Pharmacology, Regulatory, CMC, Safety, DMPK/Clinical Pharmacology, Project Management, Finance and Business Development, and will represent the operational elements of the program at senior governance forums and with external partners as required.
They will be expected to work seamlessly by working with contract research organizations (CROs) to recruit trial participants, oversee trial management, and maintain high data quality. This role reports to the Chief Medical Officer.
Ailux is an innovative biotechnology company harnessing AI to accelerate breakthrough biologic therapies in difficult immune-mediated diseases and improve the lives of patients with significant unmet medical need.
Built on intelligent design and guided by people who care about transforming healthcare, our technology is redefining what is possible in biologics development, from how we select targets to how we engineer the molecules.Ailux’s vision is to light the path to new cures and fundamentally change our approach to science and drug development to redefine current treatment paradigms.
We look to continue unlocking the potential of disease biology, integrate AI-enabled biologics development, and deliver effective clinical execution.Backed by an experienced leadership team, leading scientific advisors, a highly multidisciplinary organization, and strategic partnerships in biopharma, Ailux is approaching a key inflection point as its first wave of therapeutic programs advance toward clinical development.
This is an opportunity to play a vital role in leading programs from pre-clinical development into the clinic and through clinical proof-of-concept, shaping the pipeline and development culture of a rapidly growing biotechnology company.